STOCK TITAN

IonSense, a Leader In DART™ Mass Spectroscopy, Announces Acquisition by Bruker to Accelerate DART-MS Methods and Applications Development

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Rhea-AI Summary

Bruker Corporation (BRKR) has successfully acquired IonSense Inc., a leader in ambient DART ionization technology. This acquisition aims to enhance the development of DART ionization sources and expand applications in food analysis and forensics. IonSense will leverage Bruker's financial investments to accelerate their product development and reach a broader market. The DART technology uniquely analyzes solids, liquids, and gases without prior chromatography, offering faster sample identification. This merger positions Bruker to further tap into the $4B mass spectrometry marketplace.

Positive
  • Acquisition enhances the development of DART ionization technology.
  • Bruker's financial investment will accelerate product development.
  • Expansion into applied markets such as food analysis and forensics.
  • DART technology offers unique capabilities, improving market positioning.
Negative
  • None.

SAUGUS, Mass.--(BUSINESS WIRE)-- IonSense Inc., the innovator of ambient DART™ (Direct Analysis in Real Time) ionization technology, announces that it has been acquired by Bruker Corporation (Nasdaq: BRKR). The deal provides IonSense with the financial investments to ramp up development of the DART ionization source technology and increase efforts in developing applications in the applied markets, including food analysis and forensics.

Bruker acquires IonSense (Graphic: Business Wire)

Bruker acquires IonSense (Graphic: Business Wire)

“This merger will help us to accelerate development of DART MS and properly resource robust applications development programs,” commented the CEO of IonSense, Jeff Zonderman. “Our vision remains to use DART to empower mass spectrometers to perform better outside their traditional LC and GC workflows. We are committed to continuing sales of our DART sources for coupling with all vendors’ mass spectrometers. In partnership with Bruker, we will leverage their strong presence and reputation in analytical instrumentation, and their investments in IonSense, to introduce our enabling technology to a wider customer audience at a faster pace.”

Commenting on the acquisition, Dr. Robert Galvin, VP Applied Markets at Bruker Daltonics, stated: “We are excited about bringing this enabling technology to our customers. We believe that mass spectrometry has a broader potential in a wider range of markets than it has previously been known for. Our financial commitment to DART will ultimately enable more people to have access to the power of mass spectrometry for today’s analytical challenges.”

DART is an ionization source that, uniquely, analyzes a variety of particles (including solids, liquids and gases) without needing any sample chromatography prior to MS analysis. This removes a time-consuming step, so users can rapidly identify samples, including many that do not ionize well using other methods, at the point of need (PoN).

To find out more about the DART system, please visit www.ionsense.com or contact the company at info@ionsense.com. If you would like to find out more about DART technology, then visit https://www.ionsense.com/DART_Technology/DART_Technology/en.

About IonSense

IonSense Corporation is the leading provider of Ambient Ionization (AI) sources, systems and integrated solutions for the $4B Mass Spectrometry (MS) marketplace. Headquartered in Saugus, MA the company manufactures, sells and markets the DART® (Direct Analysis in Real Time) ionization source, the first open air ionization product to be patented and sold commercially. For further information, please visit www.ionsense.com

For media enquiries in Europe:

Claire England

claire@covalentbonds.com

+44 (0) 7808 020554



For media enquiries in the USA:

Laura Browne

laura@covalentbonds.com

+1 978 893 9618

Source: IonSense Inc.

FAQ

What is the significance of Bruker's acquisition of IonSense?

The acquisition aims to enhance the development of DART ionization technology and expand applications in key markets, leveraging Bruker's financial resources.

How will the acquisition affect Bruker's market presence?

Bruker aims to leverage IonSense's technology to introduce innovative solutions to a wider customer audience and strengthen its position in the $4B mass spectrometry market.

What industries will benefit from the DART ionization technology?

DART technology will benefit industries such as food analysis and forensics, enabling faster and more efficient sample identification.

What are the expected outcomes of the IonSense acquisition?

Expected outcomes include accelerated development of DART technology, increased market penetration, and enhanced capabilities in analytical instrumentation.

What is the DART technology used for?

DART technology is used for analyzing solids, liquids, and gases without the need for sample chromatography, streamlining the mass spectrometry process.

Bruker Corporation

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Stock Data

8.52B
103.20M
31.84%
79.71%
2.51%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
BILLERICA